Search Results - "Reingold, SC"

Defining the clinical course of multiple sclerosis : Results of an international survey by LUBLIN, F. D, REINGOLD, S. C

Get full text

Differential diagnosis of suspected multiple sclerosis: a consensus approach by Miller, DH, Weinshenker, BG, Filippi, M, Banwell, BL, Cohen, JA, Freedman, MS, Galetta, SL, Hutchinson, M, Johnson, RT, Kappos, L, Kira, J, Lublin, FD, McFarland, HF, Montalban, X, Panitch, H, Richert, JR, Reingold, SC, Polman, CH

“…Background and objectives Diagnosis of multiple sclerosis (MS) requires exclusion of diseases that could better explain the clinical and paraclinical findings…”
Get full text

Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria" by Polman, Chris H., Reingold, Stephen C., Edan, Gilles, Filippi, Massimo, Hartung, Hans-Peter, Kappos, Ludwig, Lublin, Fred D., Metz, Luanne M., McFarland, Henry F., O'Connor, Paul W., Sandberg-Wollheim, Magnhild, Thompson, Alan J., Weinshenker, Brian G., Wolinsky, Jerry S.

“…New diagnostic criteria for multiple sclerosis integrating magnetic resonance image assessment with clinical and other paraclinical methods were introduced in…”
Get full text

Interferon beta-1b in secondary progressive MS: Results from a 3-year controlled study by Panitch, Hillel, Miller, Aaron, Paty, Donald, Weinshenker, Brian

“…To evaluate the efficacy and safety of interferon beta-1b (IFNbeta-1b) in subjects with secondary progressive multiple sclerosis (SPMS). This 3-year,…”
Get full text

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis by McDonald, W. Ian, Compston, Alistair, Edan, Gilles, Goodkin, Donald, Hartung, Hans-Peter, Lublin, Fred D., McFarland, Henry F., Paty, Donald W., Polman, Chris H., Reingold, Stephen C., Sandberg-Wollheim, Magnhild, Sibley, William, Thompson, Alan, Van Den Noort, Stanley, Weinshenker, Brian Y., Wolinsky, Jerry S.

“…The International Panel on MS Diagnosis presents revised diagnostic criteria for multiple sclerosis (MS). The focus remains on the objective demonstration of…”
Get full text

The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment by Fischer, J S, Rudick, R A, Cutter, G R, Reingold, S C

“…Clinical outcome assessment in Multiple Sclerosis (MS) is challenging due to the diversity and fluctuating nature of MS symptoms. Traditional clinical scales…”
Get full text

The role of magnetic resonance techniques in understanding and managing multiple sclerosis by MILLER, D. H, GROSSMAN, R. I, REINGOLD, S. C, MCFARLAND, H. F

“…Magnetic resonance (MR) techniques have had a major impact in the last 10-15 years in understanding and managing multiple sclerosis. This review summarizes the…”
Get full text

Multiple sclerosis diagnostic criteria: three years later by Polman, Chris H, Wolinsky, Jerry S, Reingold, Stephen C

“…New diagnostic criteria for multiple sclerosis (MS) were developed by an International Panel in 2001 and have had wide distribution and discussion since…”
Get full text

Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses by Petkau, J, Reingold, SC, Held, U, Cutter, GR, Fleming, TR, Hughes, MD, Miller, DH, McFarland, HF, Wolinsky, JS

“…Background Magnetic resonance imaging (MRI) of lesions in the brain may be the best current candidate for a surrogate biological marker of clinical outcomes in…”
Get full text

The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era by McFarland, H F, Reingold, S C

“…Due to past success in testing and gaining regulatory approval for a variety of therapies in multiple sclerosis (MS), the conduct of future clinical trials has…”
Get full text

Prevalence estimates for MS in the United States and evidence of an increasing trend for women by Reingold, Stephen C

Get full text

Stem cell therapy in multiple sclerosis: promise and controversy by Duncan, ID, Goldman, S, Macklin, WB, Rao, M, Weiner, LP, Reingold, SC

“…Stem cells offer the potential for regeneration of lost tissue in neurological disease, including multiple sclerosis (MS). Their development in vitro and their…”
Get full text

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis by Whitaker, J N, McFarland, H F, Rudge, P, Reingold, S C

“…The feasibility and precision of clinical trials for the treatment of MS must be improved. Subsequent to the approval by the Food and Drug Administration of…”
Get more information

Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

“…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
Get full text

Revised estimate of the prevalence of multiple sclerosis in the United States by Anderson, D W, Ellenberg, J H, Leventhal, C M, Reingold, S C, Rodriguez, M, Silberberg, D H

“…Using three adjustments, we have revised a 1976 prevalence count for multiple sclerosis in the United States. The adjustments were made to data from a US…”
Get more information

Multiple sclerosis: Should MR criteria for dissemination in time be less stringent by Polman, Chris H., Wolinsky, Jerry S., Reingold, Stephen C.

Get full text

Combination therapy for treatment of multiple sclerosis by Lublin, F D, Reingold, S C

Get more information

Guidelines for clinical trials of new therapeutic agents in multiple sclerosis: Relations between study investigators, advisors, and sponsors by Lublin, Fred D, Reingold, Stephen C

Get full text

Advances in the understanding and treatment of multiple sclerosis. Boston, Massachusetts, USA, 28-29 October 1992 by Reingold, S C

“…Basic and applied research on multiple sclerosis (MS) has become increasingly focused on the development and testing of new therapeutic agents for this…”
Get more information

Neurological consequences of immune dysfunction: lessons from HIV infection and multiple sclerosis by Wiley, C A, Johnson, R T, Reingold, S C

“…In a recent workshop held on Sanibel Island, Florida (18-21 January 1992), the two most common neuroimmunologic diseases of young adults, multiple sclerosis…”
Get more information